Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Presentation

Poster: Epigenetic Regulation of Human Prion Expression as a Potential One-Time Treatment for Prion Disease

Download PDF